Time-varying effects of FOXA1 on breast cancer prognosis
- 18 February 2021
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 187 (3) , 867-875
Abstract
Purpose Results of previous studies on the associations between Forkhead box A1 (FOXA1) expression in breast cancer tissues and the prognosis varied depending on the follow-up durations. The present study would investigate whether there is a time-varying effect of FOXA1 in breast cancer tissues on the prognosis. Methods FOXA1 expressions were evaluated in 1041 primary invasive breast tumors with tissue microarrays by immunohistochemistry. Cox models with restricted cubic splines and Kaplan–Meier survival analysis were used to examine the associations between FOXA1 and the prognosis. Flexible parametric models were applied to explore the time-varying effect of FOXA1. Results Overall, the association between FOXA1 expression and the prognosis was not significant but varied on the time of follow-up. Compared to FOXA1 ≤ 270 of H-score, the hazard ratios (HRs) of death for those with 271–285 of FOXA1 expression increased from 0.35 (95% CI 0.14–0.86) at 6 months after diagnosis to 2.88 (95% CI 1.35–6.15) at 120 months with a crossover at around 36 months. Similar patterns were also observed for FOXA1 > 285 of H-score and for progression free survival (PFS). Moreover, when allowed both FOXA1 and estrogen receptor (ER) to change over time in the model (considering that ER had a similar time-varying effect), these time-varying effects remained for FOXA1 on both overall survival (OS) (P < 0.01) and PFS (P = 0.01) but were attenuated for ER (P = 0.13 for OS). Conclusions This study revealed an independent time-varying effect of FOXA1 on breast cancer prognosis, which would provide an insight into the roles of FOXA1 as a marker of breast cancer prognosis and may help optimize the medication strategies.Keywords
Funding Information
- National Natural Science Foundation of China (81773515, 81973115)
- Science and Technology Planning Project of Guangdong Province (2019B030316002)
This publication has 33 references indexed in Scilit:
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancerNature, 2012
- FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate CancerFrontiers in Endocrinology, 2012
- FOXA1: a transcription factor with parallel functions in development and cancerBioscience Reports, 2011
- Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast CancerAnnals of Surgical Oncology, 2011
- FOXA1: master of steroid receptor function in cancerThe EMBO Journal, 2011
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1The EMBO Journal, 2011
- FOXA1 is a key determinant of estrogen receptor function and endocrine responseNature Genetics, 2010
- FOXA1 is an essential determinant of ERα expression and mammary ductal morphogenesisDevelopment, 2010
- Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursBreast Cancer Research, 2009
- Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1Cell, 2005